We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

68 hedge funds and large institutions have $78.6M invested in BioSpecifics Technologies Corp. in 2014 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 16 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

69% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 16

60% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 10

47% more capital invested

Capital invested by funds: $53.6M → $78.6M (+$25M)

10% more funds holding

Funds holding: 6268 (+6)

Holders
68
Holders Change
+6
Holders Change %
+9.68%
% of All Funds
1.97%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
16
Increased
27
Reduced
16
Closed
10
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
DM
1
Deerfield Management
New York
$5.96M
Franklin Resources
2
Franklin Resources
California
$5.71M
Vanguard Group
3
Vanguard Group
Pennsylvania
$4.45M +$116K +3,954 +3%
Renaissance Technologies
4
Renaissance Technologies
New York
$3.85M +$1.23M +41,991 +63%
Acadian Asset Management
5
Acadian Asset Management
Massachusetts
$3.31M +$882K +30,034 +47%
BFA
6
BlackRock Fund Advisors
California
$3.21M -$189K -6,429 -7%
Wells Fargo
7
Wells Fargo
California
$3.11M +$201K +6,849 +8%
RA
8
Royce & Associates
New York
$3.06M -$393K -13,400 -13%
BIT
9
BlackRock Institutional Trust
California
$2.83M -$13.7K -468 -0.6%
TC
10
TFS Capital
Pennsylvania
$2.81M +$179K +6,108 +8%
Dimensional Fund Advisors
11
Dimensional Fund Advisors
Texas
$2.54M +$184K +6,260 +10%
Morgan Stanley
12
Morgan Stanley
New York
$2.13M +$579K +19,720 +49%
DCM
13
DAFNA Capital Management
California
$2.12M -$295K -10,034 -14%
Northern Trust
14
Northern Trust
Illinois
$2.09M +$815K +27,750 +88%
BA
15
BlackRock Advisors
Delaware
$2.07M -$307K -10,461 -15%
MOACM
16
Mutual of America Capital Management
New York
$2.01M
EI
17
EAM Investors
California
$1.96M +$1.63M +55,636 New
Charles Schwab
18
Charles Schwab
California
$1.75M +$231K +7,875 +19%
NC
19
Northpointe Capital
Michigan
$1.69M -$581K -19,800 -29%
GCP
20
GSA Capital Partners
United Kingdom
$1.6M -$135K -4,600 -9%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$1.55M +$121K +4,114 +10%
PI
22
Putnam Investments
Massachusetts
$1.3M +$17.5K +597 +2%
PAI
23
Palo Alto Investors
California
$1.25M +$709K +24,152 +216%
MCM
24
McKinley Capital Management
Alaska
$1.19M +$987K +33,615 New
Invesco
25
Invesco
Georgia
$1.14M +$733K +24,950 +339%

BSTC Hedge Fund Activity: Q3 2014 in Review

68 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q3 2014, worth a combined $78.6M — up 47% from $53.6M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new BSTC positions and 10 closed out — a net gain of 6 holders — while 27 added to existing stakes and 16 trimmed.

The largest buyer was EAM Investors, opening a new position worth an estimated $1.63M. The largest seller was Commonwealth of Pennsylvania Public School Employees Retirement System, exiting entirely with an estimated $1.01M sold.

  • 68 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q3 2014, up from 62 in Q2 2014.
  • Funds reported $78.6M of BioSpecifics Technologies Corp. stock for Q3 2014, up 47% quarter-over-quarter.
  • 16 funds opened new BioSpecifics Technologies Corp. positions in Q3 2014 and 10 closed out, a net change of +6 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q3 2014 was EAM Investors, an estimated $1.63M added.
  • The largest BioSpecifics Technologies Corp. seller in Q3 2014 was Commonwealth of Pennsylvania Public School Employees Retirement System, an estimated $1.01M sold.

Based on aggregated 13F filings for Q3 2014.